A substance in human breast milk seems to reduce the risk of mother-to-child transmission of H.I.V., scientists have reported.Researchers working in Zambia collected breast milk samples from 81 H.I.V.-positive women who transmitted the virus to their infants during breast-feeding, 86 H.I.V.-positive

The settlement is part of a broad crackdown on bribery by multinational companies in foreign countries that has hit several of the world’s biggest pharmaceutical companies.Pfizer in 2004 became the first pharmaceutical company to volunteer information about past wrongdoing to the Justice Department,

WASHINGTON — It would seem a business executive’s dream: legally pay a competitor to keep its product off the market for years.Congress has failed to stop it, and for more than a decade generic drug makers and big-name pharmaceutical companies have been winning court rulings that allowed it.Until th

More than 200 researchers investigating colon cancer tumors have found genetic vulnerabilities that could lead to powerful new treatments. The hope is that drugs designed to strike these weak spots will eventually stop a cancer that is now almost inevitably fatal once it has spread.Scientists increa

Drug-resistant HIV has been increasing in parts of sub-Saharan Africa over the last decade, according to experts writing in the Lancet.Studies on 26,000 untreated HIV-positive people in developing countries were reviewed by the team.They said resistance could build up if people fail to stick to drug

The debate over the price of the vaccine against HPV has become intenseWhen it comes to making the shot against cervical cancer the national vaccine programme, which means girls between the ages of 12-18 will receive it free, price is the matter.The debate over the price of the vaccine against Human

Welcome to iDSI, the international Decision Support Initiative. We provide a platform for supporting low and middle income country (LMIC) policymakers in making better use of healthcare resources to generate maximum health, in their journeys towards universal health coverage (UHC).

As part of a series of events coinciding with the launch of the Gates Reference Case, Tommy Wilkinson (Adviser for Health Economics, NICE International) will be speaking on Tuesday 17 June 2014 at a lunch seminar hosted by the Center for Global Development, Washington DC. If you missed our launch ev

This is a post by Amanda Glassman reproduced with permission from the Center for Global DevelopmentCost-effectiveness studies compare the costs and benefits of different interventions with the aim of improving decisions on the allocation of scarce resources for health.  Or, put simply, they allow po

NICE International launches the Gates Reference Case, a principle-based standardised methodology for good practice in the planning, conduct and reporting of economic evaluation for informing priority setting in health. The Methods for Economic Evaluation Project (MEEP) was establ